Associate Professor Eva Závadová M.D., Ph.D. Email and Phone Number

PublicationLancet. 2018 May 26;391(10135):2128-2139. doi: 10.1016/S0140-6736(18)30789https://www.ncbi.nlm.nih.gov/pubmed/29754777Recent publications are based on describing immune status of cancer patients in order to predict the prognosis and to be able to adjust the treatment of cancer patients . Education1985-1992: Medical school Charles University Prague, Czech Republic1990-1998 : Medical University of Vienna, Austria ,1992-1998: Cancer Research Institute, Department of Medicine, University of Vienna, Austria. Working on different cancer immunology projects and getting PhD degree. She focused especially on immune system of cancer patients, specificly activation of tumour associated macrophages in patients with lung, breast and ovarian cancer and modulation with proteolytic enzymes Grants Bundesministerium fur Wissenschaft und Forschung-1994-1998 and colaboration with Mucos Pharma Germany1998-2000 employee in the laboratory of Department of Gynecologic Oncology,MD Anderson Cancer Center, Houston, where she developed techniques of adaptive immune therapy, especially focused on dendritic cells vaccine development in patients with breast and ovarian cancer and modulation with proteases –,NASA subcontract NCC 9-36 , Texas Medical CenterNASA/Johnson Space Center and support from Mucos Pharma Germany and Naturally vitamins, Phoenix2000 -2005 got specialized in Internal Medicine ( Dept.of Internal medicine with focus on diabetology and nefrology, Charles University, Prague ) and additionally 2005 in Clinical Immunology and allergology ,2005-2010 Dept of clinical Immunology , Charles University Prague2007- Currently Chief doctor degree licence: Internal medicine and Immunology2010- Currently: working part time as Associate Professor of Immunology at Dept. of Oncology, 1. Medical School, Charles University, Prague, (clinical immunologist) and running private doctors clinic for allergology and immunology and internal medicine